Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 244

1.

Tetrabenazine as antichorea therapy in Huntington disease: a randomized controlled trial.

Huntington Study Group.

Neurology. 2006 Feb 14;66(3):366-72.

PMID:
16476934
2.

The long-term effect of tetrabenazine in the management of Huntington disease.

Fasano A, Cadeddu F, Guidubaldi A, Piano C, Soleti F, Zinzi P, Bentivoglio AR.

Clin Neuropharmacol. 2008 Nov-Dec;31(6):313-8. doi: 10.1097/WNF.0b013e318166da60.

PMID:
19050408
3.

Short-term effects of tetrabenazine on chorea associated with Huntington's disease.

Kenney C, Hunter C, Davidson A, Jankovic J.

Mov Disord. 2007 Jan;22(1):10-3.

PMID:
17078062
4.

A study of chorea after tetrabenazine withdrawal in patients with Huntington disease.

Frank S, Ondo W, Fahn S, Hunter C, Oakes D, Plumb S, Marshall F, Shoulson I, Eberly S, Walker F, Factor S, Hunt V, Shinaman A, Jankovic J.

Clin Neuropharmacol. 2008 May-Jun;31(3):127-33. doi: 10.1097/WNF.0b013e3180ca77ea.

PMID:
18520979
5.

Tetrabenazine as anti-chorea therapy in Huntington disease: an open-label continuation study. Huntington Study Group/TETRA-HD Investigators.

Frank S.

BMC Neurol. 2009 Dec 18;9:62. doi: 10.1186/1471-2377-9-62. Erratum in: BMC Neurol. 2011;11:18.

6.

Tetrabenazine treatment for Huntington's disease-associated chorea.

Ondo WG, Tintner R, Thomas M, Jankovic J.

Clin Neuropharmacol. 2002 Nov-Dec;25(6):300-2.

PMID:
12469001
7.

Tetrabenazine for the treatment of hyperkinetic movement disorders: a review of the literature.

Chen JJ, Ondo WG, Dashtipour K, Swope DM.

Clin Ther. 2012 Jul;34(7):1487-504. doi: 10.1016/j.clinthera.2012.06.010. Epub 2012 Jun 28. Review.

PMID:
22749259
8.

Tetrabenazine treatment in movement disorders.

Paleacu D, Giladi N, Moore O, Stern A, Honigman S, Badarny S.

Clin Neuropharmacol. 2004 Sep-Oct;27(5):230-3.

PMID:
15602104
9.

Long-term tolerability of tetrabenazine in the treatment of hyperkinetic movement disorders.

Kenney C, Hunter C, Jankovic J.

Mov Disord. 2007 Jan 15;22(2):193-7.

PMID:
17133512
10.

Treatment of chorea associated with Huntington's disease: focus on tetrabenazine.

Setter SM, Neumiller JJ, Dobbins EK, Wood L, Clark J, DuVall CA, Santiago A.

Consult Pharm. 2009 Jul;24(7):524-37. Review.

PMID:
19689181
11.

[Huntington disease: tetrabenazine compared to haloperidol in the reduction of involuntary movements].

Giménez-Roldán S, Mateo D.

Neurologia. 1989 Oct;4(8):282-7. Spanish.

PMID:
2534679
12.

Tetrabenazine: for chorea associated with Huntington's disease.

Scott LJ.

CNS Drugs. 2011 Dec 1;25(12):1073-85. doi: 10.2165/11208330-000000000-00000.

PMID:
22133328
13.

Long-term effects of tetrabenazine in hyperkinetic movement disorders.

Jankovic J, Beach J.

Neurology. 1997 Feb;48(2):358-62.

PMID:
9040721
14.

Tetrabenazine as antichorea therapy in Huntington disease: a randomized controlled trial.

Savani AA, Login IS.

Neurology. 2007 Mar 6;68(10):797; author reply 797. No abstract available.

PMID:
17339599
15.

Clozapine versus placebo in Huntington's disease: a double blind randomised comparative study.

van Vugt JP, Siesling S, Vergeer M, van der Velde EA, Roos RA.

J Neurol Neurosurg Psychiatry. 1997 Jul;63(1):35-9.

16.

Management of Huntington's disease: role of tetrabenazine.

de Tommaso M, Serpino C, Sciruicchio V.

Ther Clin Risk Manag. 2011;7:123-9. doi: 10.2147/TCRM.S17152. Epub 2011 Mar 21.

17.

Dosage effects of riluzole in Huntington's disease: a multicenter placebo-controlled study.

Huntington Study Group.

Neurology. 2003 Dec 9;61(11):1551-6.

PMID:
14663041
18.

Treatment of the symptoms of Huntington's disease: preliminary results comparing aripiprazole and tetrabenazine.

Brusa L, Orlacchio A, Moschella V, Iani C, Bernardi G, Mercuri NB.

Mov Disord. 2009 Jan 15;24(1):126-9. doi: 10.1002/mds.22376.

PMID:
19170197
19.
20.

Open-label pilot study of levetiracetam (Keppra) for the treatment of chorea in Huntington's disease.

Zesiewicz TA, Sullivan KL, Hauser RA, Sanchez-Ramos J.

Mov Disord. 2006 Nov;21(11):1998-2001.

PMID:
16941461
Items per page

Supplemental Content

Write to the Help Desk